Biomarker response to asthma treatment shouldn’t be neglected

Biomarkers can guide treatment choice in severe asthma but may also provide clinically useful information from the subsequent effects of treatment on biomarkers, Australian researchers say. A review of the evidence, led by Professor John Upham from the University of Queensland Diamantina Institute, shows the available data is inconsistent and biomarker response to treatment can ...